Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J C Oki

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Pharmacotherapy|May 1, 1995
Dyslipidemias in patients with diabetes mellitus: classification and risks and benefits of therapyJ C Oki
DICP : the Annals of Pharmacotherapy|May 1, 1989
Branched-chain amino acid support of stressed patientsJ C Oki, P G Cuddy
Pharmacotherapy|July 1, 1994
Family leave policies, job share, and child care at U.S. schools and colleges of pharmacyJ S Marinac, J C Oki
Annals of Internal Medicine|September 9, 2000
Rosiglitazone and liver failureW L Isley, J C Oki
Diabetes, Obesity & Metabolism|March 21, 2002
Hepatotoxicity of thiazolidinedionesW L Isley, J C Oki
The Annals of Pharmacotherapy|January 1, 1997
Mexiletine in the symptomatic treatment of diabetic peripheral neuropathyJ M Wright, J C Oki, L Graves
Healthcare Financial Management : Journal of the Healthcare Financial Management Association|November 5, 1991
Clinical pharmacists can ensure quality at acceptable costsD J Skaar, J C Oki, R M Elenbaas
The Diabetes Educator|July 1, 1997
Frequency and impact of SMBG on glycemic control in patients with NIDDM in an urban teaching hospital clinicJ C Oki, D L Flora, W L Isley
Annals of Internal Medicine|July 4, 1998
Troglitazone-induced hepatic failure leading to liver transplantation. A case reportB A Neuschwander-Tetri, W L Isley, J C Oki, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Pharmacotherapy|May 1, 1995
Dyslipidemias in patients with diabetes mellitus: classification and risks and benefits of therapyJ C Oki
DICP : the Annals of Pharmacotherapy|May 1, 1989
Branched-chain amino acid support of stressed patientsJ C Oki, P G Cuddy
Pharmacotherapy|July 1, 1994
Family leave policies, job share, and child care at U.S. schools and colleges of pharmacyJ S Marinac, J C Oki
Annals of Internal Medicine|September 9, 2000
Rosiglitazone and liver failureW L Isley, J C Oki
Diabetes, Obesity & Metabolism|March 21, 2002
Hepatotoxicity of thiazolidinedionesW L Isley, J C Oki
The Annals of Pharmacotherapy|January 1, 1997
Mexiletine in the symptomatic treatment of diabetic peripheral neuropathyJ M Wright, J C Oki, L Graves
Healthcare Financial Management : Journal of the Healthcare Financial Management Association|November 5, 1991
Clinical pharmacists can ensure quality at acceptable costsD J Skaar, J C Oki, R M Elenbaas
The Diabetes Educator|July 1, 1997
Frequency and impact of SMBG on glycemic control in patients with NIDDM in an urban teaching hospital clinicJ C Oki, D L Flora, W L Isley
Annals of Internal Medicine|July 4, 1998
Troglitazone-induced hepatic failure leading to liver transplantation. A case reportB A Neuschwander-Tetri, W L Isley, J C Oki, et al.
Pageof 1